West Pharmaceutical Services, Inc. (BVMF:W2ST34)

Market Cap	93.48B -36.6%
Revenue (ttm)	16.08B +4.9%
Net Income	2.62B -1.6%
EPS	35.98 +0.2%
Shares Out	n/a
PE Ratio	35.67
Forward PE	33.15
Dividend	0.09 (0.27%)
Ex-Dividend Date	Jan 27, 2026

Volume	25
Average Volume	118
Open	34.70
Previous Close	n/a
Day's Range	34.50 - 34.70
52-Week Range	32.64 - 54.14
Beta	1.19
RSI	36.88
Earnings Date	Feb 12, 2026

About BVMF:W2ST34

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhanc...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1923
• Employees: 10,600
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: W2ST34

Financial Performance

In 2024, BVMF:W2ST34's revenue was $2.89 billion, a decrease of -1.92% compared to the previous year's $2.95 billion. Earnings were $492.70 million, a decrease of -16.97%.

Financial numbers in USD